A Clinical Study of Tobradex AF
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00473070 |
Recruitment Status :
Completed
First Posted : May 14, 2007
Last Update Posted : July 29, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cataract | Drug: Tobradex AF | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 900 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | A Clinical Study of Tobradex AF |
Study Start Date : | November 2006 |
Actual Primary Completion Date : | February 2007 |
- Concentration of dexamethasone in aqueous humor following a single topical ocular administration [ Time Frame: Periodic ]
- Changes in external and internal ocular structures, intraocular pressure, vision and other side effects [ Time Frame: Periodic ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adult patients requiring cataract surgery
Exclusion Criteria:
- Age related

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00473070
United States, Pennsylvania | |
Pittsburgh | |
Pittsburgh, Pennsylvania, United States, 15122 |
Study Director: | Robert Faulkner | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00473070 |
Other Study ID Numbers: |
C-06-37 |
First Posted: | May 14, 2007 Key Record Dates |
Last Update Posted: | July 29, 2008 |
Last Verified: | July 2008 |
Cataract Lens Diseases Eye Diseases Tobramycin, Dexamethasone Drug Combination Anti-Inflammatory Agents Anti-Bacterial Agents Anti-Infective Agents |
Glucocorticoids Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs Ophthalmic Solutions Pharmaceutical Solutions |